DNA Vaccination Against Specific Pathogenic TCRs Reduces Proteinuria in Active Heymann Nephritis by Inducing Specific Autoantibodies

Journal of Immunology

Volumn 171, Issue 9, 2003, Pages 4824-4829

  Wu, Huiling ^a   Walters, Giles ^a   Knight, John F ^a   Alexander, Stephen I ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; DNA VACCINE; GAMMA INTERFERON; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN G; INTERLEUKIN 10; MESSENGER RNA; NAKED DNA; RECEPTOR ANTIBODY; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR JBETA2.6; T LYMPHOCYTE RECEPTOR VBETA13; T LYMPHOCYTE RECEPTOR VBETA5; T LYMPHOCYTE RECEPTOR VBETA7; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGEN PRESENTING CELL; ARTICLE; CELL INFILTRATION; CELL SPECIFICITY; CELL SURFACE; CLONAL VARIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE MODEL; DNA DETERMINATION; DOSE TIME EFFECT RELATION; DRUG MECHANISM; DRUG TARGETING; FLUORESCENCE ACTIVATED CELL SORTING; GLOMERULUS; HEYMANN NEPHRITIS; IMMUNIZATION; INFECTION PREVENTION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA; RAT; RECEPTOR AFFINITY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VACCINATION;

EID: 0142210398     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.9.4824     Document Type: Article

References (25)

1. Oliveira, D. B. 2002. The immunopathogenesis of membranous nephropathy. Minerva Med. 93:323.
2. Heymann, W., D. B. Hackel, S. Harwood, S. G. Wilson, and J. Hunter. 1959. Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions. Proc. Exp. Biol. Med. 100:660.
3. Salant, D. J., R. J. Quigg, and A.V. Cybulsky. 1989. Heymann nephritis: mechanism of renal injury. Kidney Int. 35:976.
4. Edgington, T. S., R. J. Glassock, J. I. Watson, and F. J. Dixon. 1967. Characterization and isolation of specific renal tubular epithelial antigens. J. Immunol. 99:1199.
5. Makker, S. P. 1993. Analysis of glomeruli-eluted Gp330 autoantibodies and of Gp330 antigen of Heymann nephritis. J. Immunol. 151:6500.
6. Quiza, C. G., P. L. Leenaerts, and B. M. Hall. 1992. The role of T cells in the mediation of glomerular injury in Heymann's nephritis in the rat. Int. Immunol. 4:423.
7. Penny, M. J., R. A. Boyd, and B. M. Hall. 1997. Role of T cells in the mediation of Heymann nephritis. ii. Identification of Th1 and cytotoxic cells in glomeruli. Kidney Int. 51:1059.
8. + T cell depletion prevents proteinuria in active Heymann nephritis. J. Exp. Med. 188:1775.
9. Matsumoto, Y., Y. Jee, and M. Sugisaki. 2000. Successful TCR-based immunotherapy for autoimmune myocarditis with DNA vaccines after rapid identification of pathogenic TCR. J. Immunol. 164:2248.
10. Walters, G., H. Wu, and J. F. Knight. 2001. Glomerular T cells in Heymann nephritis. Clin. Exp. Immunol. 126:319.
11. Waisman, A., P. J. Ruiz, D. L. Hirschberg, A. Gelman, J. R. Oksenberg, S. Brocke, F. Mor, I. R. Cohen, and L. Steinman. 1996. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat. Med. 2:899.
12. De Heer, E., M. R. Daha, and L. A. van Es. 1984. Lymph node cells from rats with Heymann's nephritis produce in vitro autoantibodies directed against purified renal tubular antigen. Immunology 52:743.
13. Edgington, T. S., R. J. Glassock, and F. J. Dixon. 1968. Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenestic antigen. J. Exp. Med. 127:555.
14. Wu, H., G. Y. Zhang, and J. F. Knight. 2000. T cell lines specific for a synthetic Heymann nephritis peptide derived from the receptor-associated protein. Clin. Exp. Immunol. 121:157.
15. Gold, D. P., M. Vainiene, B. Celnik, S. Wiley, C. Gibbs, G. A. Hashim, A. A. Vandenbark, and H. Offner. 1992. Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rats. II. Biased TCR Vβ expression predominates in spinal cord infiltrating T cells. J. Immunol. 148:1712.
16. Koga, Y., N. Caccia, B. Toyonaga, R. Spolski, Y. Yanagi, Y. Yoshikai, and T. W. Mak. 1986. A human T cell-specific cDNA clone (YT16) encodes a protein with extensive homology to a family of protein-tyrosine kinases. Eur. J. Immunol. 16:1643.
17. Nielsen, P. R., L. Ellgaard, M. Etzerodt, H. C. Thogersen, and F. M. Poulsen. 1997. The solution structure of the N-terminal domain of α2-macroglobulin receptor-associated protein. Proc. Natl. Acad. Sci. USA 94:7521.
18. Acha-Orbea, H., D. J. Mitchell, L. Timmermann, D. C. Wraith, G. S. Tausch, M. K. Waldor, S. S. Zamvil, H. O. McDevitt, and L. Steinman. 1988. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54:263.
19. Urban, J. L., V. Kumar, D. H. Kono, C. Gomez, S. J. Horvath, J. Clayton, D. G. Ando, E. E. Sercarz, and L. Hood. 1988. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy see comments. Cell 54:577.
20. Spicer, S. T., H. Ha, R. A. Boyd, X. Y. He, N. Carter, G. Tran, M. J. Penny, S. J. Hodgkinson, and B. M. Hall. 2001. IL-4 therapy prevents the development of proteinuria in active Heymann nephritis by inhibition of Tc1 cells. J. Immunol. 167:3725.
21. Vignes, C., E. Chiffoleau, S. Brouard, P. Douillard, D. Coudreuse, J. P. Soulillou, and M. C. Cuturi. 2000. Anti-TCR Vβ-specific DNA vaccination prolongs heart allograft survival in adult rats. Eur. J. Immunol. 30:2460.
22. + T cell clone in the induction of allograft tolerance by donor-specific blood transfusion. J. Immunol. 165:96.
23. Matsumoto, Y. 2000. Characterization of T cell receptor (TCR) of organ-specific autoimmune disease-inducing T cells and TCR-based immunotherapy with DNA vaccines. J. Neuroimmunol. 110:1.
24. Bankovich, A. J., and K. C. Garcia. 2003. Not just any T cell receptor will do. Immunity 18:7.
25. Schaft, N., R. A. Willemsen, J. De Vries, B. Lankiewicz, B. W. Essers, J. W. Gratama, C. G. Figdor, R. L. Bolhuis, R. Debets, and G. J. Adema. 2003. Peptide fine specificity of anti-glycoprotein 100 CTL Is preserved following transfer of engineered TCRαβ genes into primary human T lymphocytes. J. Immunol. 170:2186.